These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 21849968

  • 21. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
    Behar DM, Rosset S, Tzur S, Selig S, Yudkovsky G, Bercovici S, Kopp JB, Winkler CA, Nelson GW, Wasser WG, Skorecki K.
    Hum Mol Genet; 2010 May 01; 19(9):1816-27. PubMed ID: 20144966
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.
    Genovese G, Tonna SJ, Knob AU, Appel GB, Katz A, Bernhardy AJ, Needham AW, Lazarus R, Pollak MR.
    Kidney Int; 2010 Oct 01; 78(7):698-704. PubMed ID: 20668430
    [Abstract] [Full Text] [Related]

  • 25. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis.
    Lin CP, Adrianto I, Lessard CJ, Kelly JA, Kaufman KM, Guthridge JM, Freedman BI, Anaya JM, Alarcón-Riquelme ME, BIOLUPUS and GENLES Networks, Pons-Estel BA, Martin J, Glenn S, Adler A, Bae SC, Park SY, Bang SY, Song YW, Boackle SA, Brown EE, Edberg JC, Alarcón GS, Petri MA, Criswell LA, Ramsey-Goldman R, Reveille JD, Vila LM, Gilkeson GS, Kamen DL, Ziegler J, Jacob CO, Rasmussen A, James JA, Kimberly RP, Merrill JT, Niewold TB, Scofield RH, Stevens AM, Tsao BP, Vyse TJ, Langefeld CD, Moser KL, Harley JB, Gaffney PM, Montgomery CG.
    Genes Immun; 2012 Apr 01; 13(3):232-8. PubMed ID: 22189356
    [Abstract] [Full Text] [Related]

  • 26. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
    Tzur S, Rosset S, Skorecki K, Wasser WG.
    Nephrol Dial Transplant; 2012 Apr 01; 27(4):1498-505. PubMed ID: 22357707
    [Abstract] [Full Text] [Related]

  • 27. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
    Tayo BO, Kramer H, Salako BL, Gottesman O, McKenzie CA, Ogunniyi A, Bottinger EP, Cooper RS.
    Int Urol Nephrol; 2013 Apr 01; 45(2):485-94. PubMed ID: 22956460
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population.
    Colares VS, Titan SM, Pereira Ada C, Malafronte P, Cardena MM, Santos S, Santos PC, Fridman C, Barros RT, Woronik V.
    PLoS One; 2014 Apr 01; 9(3):e87716. PubMed ID: 24658608
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
    Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS, Family Investigation of Nephropathy and Diabetes Research Group.
    Nat Genet; 2008 Oct 01; 40(10):1185-92. PubMed ID: 18794854
    [Abstract] [Full Text] [Related]

  • 33. Gene-gene interactions in APOL1-associated nephropathy.
    Divers J, Palmer ND, Lu L, Langefeld CD, Rocco MV, Hicks PJ, Murea M, Ma L, Bowden DW, Freedman BI.
    Nephrol Dial Transplant; 2014 Mar 01; 29(3):587-94. PubMed ID: 24157943
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. APOL1 variants associate with increased risk of CKD among African Americans.
    Foster MC, Coresh J, Fornage M, Astor BC, Grams M, Franceschini N, Boerwinkle E, Parekh RS, Kao WH.
    J Am Soc Nephrol; 2013 Sep 01; 24(9):1484-91. PubMed ID: 23766536
    [Abstract] [Full Text] [Related]

  • 36. In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.
    Anderson BR, Howell DN, Soldano K, Garrett ME, Katsanis N, Telen MJ, Davis EE, Ashley-Koch AE.
    PLoS Genet; 2015 Jul 01; 11(7):e1005349. PubMed ID: 26147622
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ, AASK Study Investigators, CRIC Study Investigators.
    N Engl J Med; 2013 Dec 05; 369(23):2183-96. PubMed ID: 24206458
    [Abstract] [Full Text] [Related]

  • 40. A genome-wide association study for diabetic nephropathy genes in African Americans.
    McDonough CW, Palmer ND, Hicks PJ, Roh BH, An SS, Cooke JN, Hester JM, Wing MR, Bostrom MA, Rudock ME, Lewis JP, Talbert ME, Blevins RA, Lu L, Ng MC, Sale MM, Divers J, Langefeld CD, Freedman BI, Bowden DW.
    Kidney Int; 2011 Mar 05; 79(5):563-72. PubMed ID: 21150874
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.